Vol 13, No 6 (2017)
Case report
Published online: 2018-01-04
Page views 641
Article views/downloads 508
Get Citation

Connect on Social Media

Connect on Social Media

Effectiveness of nivolumab in an elderly patient with metastatic BRAF-negative melanoma originating from the anal region

Jacek Calik
DOI: 10.5603/OCP.2017.0032
Oncol Clin Pract 2017;13(6):308-310.

Abstract

High serum concentration of lactate dehydrogenase (LDH) is associated with poor prognosis in patients with metastatic cutaneous melanoma. Herein, we present a case of a 92-year-old patient with metastatic melanoma and negative prognostic factors treated with anti-PD-1 antibody nivolumab. The therapy yielded excellent clinical results: significant regression of metastatic lesions and improvement in the patient’s performance status. The presented case confirms previously reported observations regarding high clinical activity and acceptable safety profile of nivolumab in elderly patients.

Article available in PDF format

Purchase Subscription

References

  1. Brudnik U, Wojas-Pelc A, Branicki W. Genetyczne uwarunkowania czerniaka. Post Dermatol Alergol. 2006; 1: 21–25.
  2. Callahan MK, Wolchok JD. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol. 2013; 94(1): 41–53.
  3. Elias R, Morales J, Rehman Y, et al. Immune Checkpoint Inhibitors in Older Adults. Curr Oncol Rep. 2016; 18(8): 47.
  4. Krzakowski M, Warzocha K. Zalecenia postępowania diagnostyczno - terapeutycznego w nowotworach złośliwych. Via Medica, Gdańsk 2013: 422.
  5. Mackiewicz J, Kwinta Ł. Nowe terapie celowane stosowane u chorych na czerniaka uogólnionego. Współczesna Onkologia. 2010; 14(1): 15–22.
  6. Ruka W, Nowecki Z, Rutkowski P. Czerniaki skóry u dorosłych monografia. Medipage. 2005: Warszawa.
  7. Rutkowski P. Nowotwory złośliwe skóry. Via Medica 2014.
  8. Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol Oncol. 2011; 5(2): 124–136.